![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | G01N 33/574 | (2006.01) |
A61K 39/395 | (2006.01) | ||
A61K 39/00 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 16/28 | (2006.01) |
(11) | Number of the document | 3631454 |
(13) | Kind of document | T |
(96) | European patent application number | 18735009.5 |
Date of filing the European patent application | 2018-05-30 | |
(97) | Date of publication of the European application | 2020-04-08 |
(45) | Date of publication and mention of the grant of the patent | 2023-09-13 |
(46) | Date of publication of the claims translation | 2023-11-27 |
(86) | Number | PCT/US2018/035134 |
Date | 2018-05-30 |
(87) | Number | WO 2018/222718 |
Date | 2018-12-06 |
(30) | Number | Date | Country code |
201762512648 P | 2017-05-30 | US | |
201762513813 P | 2017-06-01 | US | |
201762555176 P | 2017-09-07 | US | |
201762582178 P | 2017-11-06 | US |
(72) |
NOVOTNY, James Jr. , US
LONBERG, Nils , US
HEDVAT, Cyrus , US
CLYNES, Raphael , US
LOCKE, Darren , US
COGSWELL, John P. , US
JACKSON, Jeffrey , US
HARBISON, Christopher , US
EDWARDS, Robin , US
|
(73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | LAG-3 atžvilgiu teigiamų navikų gydymas |
TREATMENT OF LAG-3 POSITIVE TUMORS |
Payment date | Validity (years) | Amount | |
2025-04-24 | 8 | 185.00 EUR |
2026-05-30 |